SCHEMBL19380982

SCHEMBL19380982

Nc1cc(C(Cc2ccccc2)c2ccccc2F)c(N)c(N)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MPO P05164 3/20 0.43
▸ CYP3A4 P08684 3/20 0.43
▸ IDO1 P14902 2/20 0.38
▸ TDO2 P48775 2/20 0.38
▸ F2 P00734 2/20 0.37
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ PPARG P37231 1/20 0.34
▸ PPARA Q07869 1/20 0.34
▸ CNR2 P34972 1/20 0.34
▸ PDE4A P27815 1/20 0.34
▸ ANPEP P15144 1/20 0.33
▸ EPHX1 P07099 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ ALPI P09923 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ PTGS1 P23219 1/20 0.32
▸ XIAP P98170 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19359271 0.82 MPO (0.60) MPOCYP3A4NPC1RAB9ASMN1; SMN2
SCHEMBL19359405 0.76 MPO (0.46) MPOCYP3A4IDO1TDO2F2
SCHEMBL19381019 0.73 MPO (0.47) MPOCYP3A4NPC1RAB9ASMN1; SMN2
SCHEMBL19380955 0.72 MPO (0.46) MPOCYP3A4EPHX1NPSR1HSD17B10
SCHEMBL19359217 0.72 MPO (0.46) MPOCYP3A4PDE4A
SCHEMBL19381023 0.71 HRH1 (0.52) MPOCYP3A4
SCHEMBL19380978 0.69 MPO (0.64) MPOCYP3A4
SCHEMBL19380918 0.67 MPO (0.67) MPOCYP3A4
SCHEMBL3280996 0.67 EPHX1 (0.50) IDO1TDO2PPARGPPARACNR2
SCHEMBL19359428 0.65 SLC6A2 (0.58) MPOCYP3A4NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017161145-A1 TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE AND/OR EPX BRISTOL-MYERS SQUIBB COMPANY (US) 2017-09-21 — — WO disclosed
Send feedback